Hospitals can’t force patients to buy medicines from their pharmacies: Maha FDA

Mumbai: Food and Drug Administration (FDA) commissioner Tukaram Mundhe on Friday issued a directive to hospitals and nursing homes across the state to not make it binding on patients and their relatives to purchase medicines from their in-house pharmacies.

“By law, no one can be forced to buy medicines from a particular pharmacy. We have passed orders today. Patients can buy medicines wherever they wish,” Mundhe said while addressing a press conference at the FDA headquarters.

A chief executive officer of a leading hospital in Mumbai said, “In our hospital, we provide medicines to in-house patients, but there is no pharmacy for outpatients. Bigger hospitals in Mumbai don’t force any patient to buy medicines in-house, but smaller ones do.”

FDA officials said the action was mainly targeted at small nursing homes/ poly clinics/ small hospitals that insist on patients buying medicines from their in-house store or a particular pharmacy.

“In one case, we found that a leading doctor in the eastern suburbs owned a pharmacy which only sold brands prescribed by him. While patients were asked to buy medicines only from that shop, it did not have medicines of the same composition from other brands, which may have cost lesser,” an FDA inspector said, requesting anonymity.

Related Posts

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’